Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Keith Lamont Cummings Insider Profile
4 Followers
Keith Lamont Cummings, CFO at Pliant Therapeutics, holds 282.12K shares in Pliant Therapeutics (Ticker: PLRX).
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+29.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Keith Lamont Cummings's holdings
Insider Roles
CFO
Roles that Keith Lamont Cummings holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jun 09, 2020 - Jun 09, 2021
Return:+44.80%
The most profitable trade made by Keith Lamont Cummings
Keith Lamont Cummings's Trading History
List of latest transactions for each holding click on a transaction to see Keith Lamont Cummings's performance on stock
You May Also Like
Keith Lamont Cummings insider profile FAQ
What is the percentage of profitable transactions made by Keith Lamont Cummings?
The percentage of profitable transactions made by Keith Lamont Cummings is 100%.
What is the average return per transaction made by Keith Lamont Cummings?
The average return per transaction made by Keith Lamont Cummings is 29.90%.
What stocks does Keith Lamont Cummings hold?
Keith Lamont Cummings holds: PLRX stocks.
What was Keith Lamont Cummings’s latest transaction?
Keith Lamont Cummings latest transaction was an Uninformative Sell of $126.13K.
What was Keith Lamont Cummings's most profitable transaction?
Keith Lamont Cummings’s most profitable transaction was an Informative Buy of PLRX stock on June 9, 2020. The return on the trade was 44.80%.
What is Keith Lamont Cummings's role in Pliant Therapeutics?
Keith Lamont Cummings's role in Pliant Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.